Literature DB >> 24115223

Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulants.

Martin Stieler1, Johannes Weber, Martin Hils, Peter Kolb, Andreas Heine, Christian Büchold, Ralf Pasternack, Gerhard Klebe.   

Abstract

Entities:  

Keywords:  anticoagulation; calcium; drug design; structure elucidation; transglutaminase

Mesh：

Substances：

Year:  2013        PMID： 24115223     DOI： 10.1002/anie.201305133

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  23 in total

1.  Coagulation factor XIIIa is inactivated by plasmin.

Authors:  Woosuk S Hur; Nima Mazinani; X J David Lu; Heidi M Britton; James R Byrnes; Alisa S Wolberg; Christian J Kastrup
Journal:  Blood       Date:  2015-09-10       Impact factor: 22.113

2.  Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.

Authors:  Prakash G Doiphode; Marina V Malovichko; Kelly Njine Mouapi; Muriel C Maurer
Journal:  Anal Biochem       Date:  2014-04-19       Impact factor: 3.365

3.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

4.  Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

Authors:  Charlotte A Bäuml; Thomas Schmitz; Ajay Abisheck Paul George; Monica Sudarsanam; Kornelia Hardes; Torsten Steinmetzer; Lori A Holle; Alisa S Wolberg; Bernd Pötzsch; Johannes Oldenburg; Arijit Biswas; Diana Imhof
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

Review 5.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

6.  Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Authors:  Anna D Protopopova; Andrea Ramirez; Dmitry V Klinov; Rustem I Litvinov; John W Weisel
Journal:  J Thromb Haemost       Date:  2019-03-14       Impact factor: 5.824

7.  Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.

Authors:  Boris A Anokhin; William L Dean; Kerrie A Smith; Matthew J Flick; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  FEBS J       Date:  2019-08-28       Impact factor: 5.542

8.  Ethacrynic acid is an inhibitor of human factor XIIIa.

Authors:  Srabani Kar; Kayla Vu; Madhusoodanan Mottamal; Rami A Al-Horani
Journal:  BMC Pharmacol Toxicol       Date:  2022-06-01       Impact factor: 2.605

9.  Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.

Authors:  Rasmus Iversen; Simon Mysling; Kathrin Hnida; Thomas J D Jørgensen; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

10.  Biochemical Characterization of Medaka (Oryzias latipes) Transglutaminases, OlTGK1 and OlTGK2, as Orthologues of Human Keratinocyte-Type Transglutaminase.

Authors:  Ayaka Kikuta; Eri Furukawa; Ryota Ogawa; Natsuki Suganuma; Mai Saitoh; Toshiyuki Nishimaki; Takafumi Katsumura; Hiroki Oota; Tadafumi Kawamoto; Hideki Tatsukawa; Hisashi Hashimoto; Kiyotaka Hitomi
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.